Cancer-drug shortages in the U.S. have caused hundreds of clinical trials to be stopped or delayed, threatening progress on new treatments, a top health official told Congress Friday. Howard Koh, assistant secretary of health for the Department of Health and Human Services, said drug shortages are “dramatically affecting clinical trials.” Dr. Koh testified Friday before the House Energy and Commerce Subcommittee on Health during a hearing on drug shortages
